Publications & Thought Leadership

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in the United States

American Health-System Pharmacy (ASHP mid-year)

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ

Budget impact of subcutaneous immunoglobulin, intravenous immunoglobulin and Efgartigimod Alfa in patients with chronic inflammatory demyelinating polyneuropathy in the United States

AANEM

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

ISPOR 2024

Mallick R, Carlton R, van Stiphout J, Hubsch A, Lahue BJ

Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

ISPOR 2023

Schwander B, Lahue BJ, Cribbs KA, Czado S

The Burden of Systemic Mastocytosis in the EU: Evidence From the PRISM Patient Survey

ISPOR EU 2023

Mesa R, Triggiani M, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Annals of Allergy, Asthma & Immunology

Tachdjian R, Chang R, DerSarkissian M, Cribbs K, Lahue B, Czado S, Desai V

Current State of Health Economic Models in Hereditary Angioedema

ISPOR EU 2023

Tachdjian R, Lahue BJ, Cribbs KA, Fang DK, Czado S, Goga L, Desai V, Rautenberg T, Schwander B

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S

A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

ISPOR 2023

Soteres DF, Cribbs KA, Czado S

Diagnosis Patterns in Patients with Systemic Mastocytosis in Europe and United Kingdom

ISPOR EU 2023

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S

Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections

Immunotherapy

Lahue BJ, Mallick R, Zhang X, Heidt J, Song Y, Koenig AS, Espinoza G

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: A Real‑World Analysis of Patients, Including Those with Hematological Malignancies

Blood

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: Real World Analysis of Patients, Including Those with Hematological Malignancies

American Society of Hematology Annual Meeting (ASH) 2021

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

BMC Immunology

Mallick R, Henderson T, Lahue BJ, Kafal A, Bassett P, Scalchunes C

TAXUS-IV Investigators. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial

J Am Coll Cardiol

Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ

Medicare costs and health care resource utilization associated with atrial fibrillation in the elderly

Journal of Medical Economics

Pelletier EM, Hernandez J, Clark MA, Lahue BJ, Reyes CM, Morady F

Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?

American Journal of Managed Care

Lahue BJ, Hughes K, Hills BJ, Li SS, Hiatt JC

Adherence to Insulin Pen Therapy is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus

American Health Drug Benefits

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Pen Needle Length And Persistence Among Insulin Pen Users With Type 2 Diabetes Mellitus

ISPOR 2014

Manocchio J, Chandran A, Bonafede MM, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Burden of Health Resource Utilization Among Insulin Pen Users with Type 2 Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Adherence to Insulin Therapy may Substantially Reduce Costs Associated with Health Resource Utilization among Insulin Pen Users with Type II Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Economic Impact of Hydro ThermAblater® (HTA) Endometrial Ablation versus Hysterectomy for Dysfunctional Uterine Bleeding (DUB)

American Association of Gynecologic Laparoscopy

[Lahue] Justason BJ

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique and Uganda

Vaccine

Yang W, Parisi M, Lahue BJ, Uddin MJ, Bishai D

Examining the Impact of Country-level Factors of Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

16th Annual ISPOR European Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D

Controlling Vaccine Wastage with Smaller Vials: A Cost-Minimization Model for Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

7th Annual Vaccine and ISV Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D

Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease

Milliman Actuarial White Paper

Fitch K, Iwasaki K, Pyenson B

Does First-line Therapy Impact Clostridium difficile-associated Disease (CDAD) Recurrence Hospitalizations?

Infectious Diseases Society of America (IDSA) Annual Meeting

Lahue BJ

The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences

Journal of Infection Control and Hospital Epidemiology

O'Brien JA, Lahue BJ, Caro JJ, Davidson DM

Increased Management Needs, Functional Dependency and Staff Resources for Nursing Home Residents with Clostridium difficile-Associated Diarrhea (CDAD)

29th Annual Symposium American Medical Directors Association

Lahue BJ

Clostridium Difficile-Associated Diarrhea (CDAD) In Acute Hospitals - A Prevalent Cost Issue

ISPOR 2006

OBrien JA, PitoniakMorse C, Lahue BJ, Davidson D, Wilson D, Caro JJ

Using advanced simulation modeling to examine the impact of increased resources on patient throughput in outpatient care

Value in Health

Lahue BJ, Lacey MJ, Dronzek R

Patient Throughput and Staff Efficiency in an Outpatient Health Care Setting

6th Annual Simulation Solutions Conference

[Lahue] Justason BJ

Home care workers’ experiences of client death and disenfranchised grief

Qualitative Health Research

Tsui EK, Franzosa E, Cribbs KA, Baron S

Advocacy at the end of life: Meeting the needs of vulnerable patients

Social Work in Health Care

Nedjat-Haiem FR, Carrion IV, Cribbs K, Lorenz K

Severity, Manifestations, and Consequences of Violence among Pregnant Adolescents

Journal of Adolescent Health

Covington DL, [Lahue] Justason BJ, Wright LN

Treatment of Unruptured Intracranial Aneurysms: A Nationwide Assessment of Effectiveness

American Journal of Neuroradiology

Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF

PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Ethan Donnelly; Linda Upchurch; Samantha Watson; Betsy J. Lahue

Clinical and safety outcomes in unresectable, very early and early-stage hepatocellular carcinoma following Irreversible Electroporation (IRE) and Transarterial Chemoembolization (TACE): A systematic literature review and meta-analysis

PLOS ONE

Kristen A. Cribbs; Wesley T. Baisley; Betsy J. Lahue; Praveen Peddu

Burden of Systemic Mastocytosis in Europe and the UK: Interim Results from PRISM Patient Survey

ECRD 2024

Hobart J, Radia DH, Triggiani M, Butt NM, Drummond M, Baisley W, Lahue BJ, Green T, Powell D, Gressier-Sayag C, Mesa R

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation

Urology

Cribbs KA, Manning EF, Zhou J, Lahue BJ, Polascik TJ

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ

Assessment of Physician Treatment Preferences for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

National Comprehensive Cancer Network, Journal of the National Comprehensive Cancer Network

Gao W, Gaburo K, Lahue B, Davies K, Ukropec J, Jun M

Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: results of the TouchStone SM Patient Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC

Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

American Society of Hematology Annual Meeting (ASH)

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P

Health technology assessment on cervical cancer screening, 2000-2014

Int J Technol Assess Health Care

Lahue BJ, Baginska E, Li SS, Parisia M

National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs

American Health Drug Benefits

Lahue BJ, Pyenson B, Iwasaki K, Blumen HE, Forray S, Rothschild JM

Data Linkage For Cervical Cancer Outcomes: Is There an Evidence Base for Public Health Decision-Making?

17th Annual ISPOR

Lahue BJ, Lin AY, Crilly HJ

A Review of Health Technology Assessments (HTA) for Cervical Cancer Screening Technologies

17th Annual ISPOR

Lahue BH, Baginska E

Capturing Real‐World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for InformedHealthcare Decisions?

Journal of Evaluation in Clinical Practice

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ

PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

ISPOR 2025, Value in Health 28(S1)

Lake D. Murphy; Betsy J. Lahue

Capturing Real-World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for Informed Healthcare Decisions?

Journal of Evaluation in Clinical Practice

Kristen A. Cribbs; Lucas T. A. Blackmore; Asia R. Banks; Da Sol Kim; Betsy J. Lahue

PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue

PT13 Clinician-Reported Outcomes - A Rare Opportunity for Orphan Labels?

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in FDA Orphan Drug Labels

Value in Health

Kristen A. Cribbs; Lucas T. A. Blackmore; Michael R. McGovern; Betsy J. Lahue

Capturing real-world rare disease patient journeys: Are current methodologies sufficient?

ISPOR EU 2024

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with CIDP in the United States (P10-11.028)

AAN 2025, Neurology 104(7_Supplement_1)

Rajiv Mallick; Alphonse Hubsch; Rashad Carlton; Joris van Stiphout; Betsy Lahue

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Annals of Allergy, Asthma & Immunology

Tachdjian R, Chang R, DerSarkissian M, Cribbs K, Lahue B, Czado S, Desai V

Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections

Immunotherapy

Lahue BJ, Mallick R, Zhang X, Heidt J, Song Y, Koenig AS, Espinoza G

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: A Real‑World Analysis of Patients, Including Those with Hematological Malignancies

Blood

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: Real World Analysis of Patients, Including Those with Hematological Malignancies

American Society of Hematology Annual Meeting (ASH) 2021

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

American Society of Hematology Annual Meeting (ASH)

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P

Adherence to Insulin Pen Therapy is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus

American Health Drug Benefits

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Pen Needle Length And Persistence Among Insulin Pen Users With Type 2 Diabetes Mellitus

ISPOR 2014

Manocchio J, Chandran A, Bonafede MM, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Characterization of Injectable Medication Errors in the Hospital Setting: A Retrospective Analysis

18th Annual ISPOR

Baginska EA, Kelley L, Lahue BJ

Burden of Health Resource Utilization Among Insulin Pen Users with Type 2 Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Adherence to Insulin Therapy may Substantially Reduce Costs Associated with Health Resource Utilization among Insulin Pen Users with Type II Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ

Does First-line Therapy Impact Clostridium difficile-associated Disease (CDAD) Recurrence Hospitalizations?

Infectious Diseases Society of America (IDSA) Annual Meeting

Lahue BJ

Increased Management Needs, Functional Dependency and Staff Resources for Nursing Home Residents with Clostridium difficile-Associated Diarrhea (CDAD)

29th Annual Symposium American Medical Directors Association

Lahue BJ

Medicare costs and health care resource utilization associated with atrial fibrillation in the elderly

Journal of Medical Economics

Pelletier EM, Hernandez J, Clark MA, Lahue BJ, Reyes CM, Morady F

PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Ethan Donnelly; Linda Upchurch; Samantha Watson; Betsy J. Lahue

Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?

ISPOR 2024

Baisley W, Lahue BJ

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

European Journal of Hospital Pharmacy

Eijsink JFH, Weiss M, Taneja A, Edwards E, Girgis H, Lahue BJ, Cribbs KA, Postma M

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

ISPOR 2024

Mallick R, Carlton R, van Stiphout J, Hubsch A, Lahue BJ

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

European Journal of Hospital Pharmacy

Eijsink JFH, Weiss M, Taneja A, Edwards T, Girgis H, Lahue BJ, Cribbs KA, Postma M

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ

Making the case for pre-filled syringes: development and utilisation of an economic model

European Journal of Hospital Pharmacy

Postma MJ, Weiss M, Edwards T, Girgis H, Cribbs K, Acker E, Lahue BJ

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique and Uganda

Vaccine

Yang W, Parisi M, Lahue BJ, Uddin MJ, Bishai D

Examining the Impact of Country-level Factors of Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

16th Annual ISPOR European Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D

Controlling Vaccine Wastage with Smaller Vials: A Cost-Minimization Model for Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

7th Annual Vaccine and ISV Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D

National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs

American Health Drug Benefits

Lahue BJ, Pyenson B, Iwasaki K, Blumen HE, Forray S, Rothschild JM

Decreased Epoetin Utilization Associated with Conversion to Ferumoxytol IV Iron Protocol

American Society of Nephrology (ASN) Renal Week Meeting

Sharma A, Lahue BJ

Efficiency Outcomes Associated with Increased Ferumoxtyol Use in an Infusion Clinic

American Society of Hematology Annual Meeting (ASH)

Meyers M, Erdal E, Khan C, McKee A, Lahue BJ

Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease

Milliman Actuarial White Paper

Fitch K, Iwasaki K, Pyenson B

Inclusion of indirect cost in economic outcome analyses of medical devices: How important is it?

6th Annual International Society of Pharmacoeconomics and Outcomes Research

Subramanian S, [Lahue] Justason BJ

Economic Impact of Hydro ThermAblater® (HTA) Endometrial Ablation versus Hysterectomy for Dysfunctional Uterine Bleeding (DUB)

American Association of Gynecologic Laparoscopy

[Lahue] Justason BJ

The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences

Journal of Infection Control and Hospital Epidemiology

O'Brien JA, Lahue BJ, Caro JJ, Davidson DM

Treatment of Unruptured Intracranial Aneurysms: A Nationwide Assessment of Effectiveness

American Journal of Neuroradiology

Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF

TAXUS-IV Investigators. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial

J Am Coll Cardiol

Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ

Clostridium Difficile-Associated Diarrhea (CDAD) In Acute Hospitals - A Prevalent Cost Issue

ISPOR 2006

OBrien JA, PitoniakMorse C, Lahue BJ, Davidson D, Wilson D, Caro JJ

Patient Throughput and Staff Efficiency in an Outpatient Health Care Setting

6th Annual Simulation Solutions Conference

[Lahue] Justason BJ

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with CIDP in the United States (P10-11.028)

AAN 2025, Neurology 104(7_Supplement_1)

Rajiv Mallick; Alphonse Hubsch; Rashad Carlton; Joris van Stiphout; Betsy Lahue

Capturing Real‐World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for InformedHealthcare Decisions?

Journal of Evaluation in Clinical Practice

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in the United States

American Health-System Pharmacy (ASHP mid-year)

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ

Budget impact of subcutaneous immunoglobulin, intravenous immunoglobulin and Efgartigimod Alfa in patients with chronic inflammatory demyelinating polyneuropathy in the United States

AANEM

Capturing Real-World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for Informed Healthcare Decisions?

Journal of Evaluation in Clinical Practice

Kristen A. Cribbs; Lucas T. A. Blackmore; Asia R. Banks; Da Sol Kim; Betsy J. Lahue

PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue

Clinical and safety outcomes in unresectable, very early and early-stage hepatocellular carcinoma following Irreversible Electroporation (IRE) and Transarterial Chemoembolization (TACE): A systematic literature review and meta-analysis

PLOS ONE

Kristen A. Cribbs; Wesley T. Baisley; Betsy J. Lahue; Praveen Peddu

PT13 Clinician-Reported Outcomes - A Rare Opportunity for Orphan Labels?

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in FDA Orphan Drug Labels

Value in Health

Kristen A. Cribbs; Lucas T. A. Blackmore; Michael R. McGovern; Betsy J. Lahue

Does Availability of Rare Disease Treatment Improve Time to Diagnosis?

ISPOR 2024

Baisley W

Capturing real-world rare disease patient journeys: Are current methodologies sufficient?

ISPOR EU 2024

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ

Can Artificial Intelligence Tools Enhance Data Abstraction During Systematic Literature Reviews?

ISPOR 2024

Cribbs KA, Baisley W, Blackmore LTA, Lahue BJ

An Investigation of Patient Journey Assessment in Rare Disease

ISPOR 2024

Cribbs KA, Kim DS, Lahue BJ

Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

ISPOR 2023

Schwander B, Lahue BJ, Cribbs KA, Czado S

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation

Urology

Cribbs KA, Manning EF, Zhou J, Lahue BJ, Polascik TJ

Current State of Health Economic Models in Hereditary Angioedema

ISPOR EU 2023

Tachdjian R, Lahue BJ, Cribbs KA, Fang DK, Czado S, Goga L, Desai V, Rautenberg T, Schwander B

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S

A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

ISPOR 2023

Soteres DF, Cribbs KA, Czado S

Diagnosis Patterns in Patients with Systemic Mastocytosis in Europe and United Kingdom

ISPOR EU 2023

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S

Non-Systematic Literature Reviews: Can AI enhance current methods?

ISPOR EU 2023

Baisley W, Perriello L, Shoushi G, Lahue BJ

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S

A Systematic Review of the Effectiveness of Health Information Technology Interventions in Improving Medication Adherence

19th Annual ISPOR

Nigam S, Mitra D, Lahue BJ

Data Linkage For Cervical Cancer Outcomes: Is There an Evidence Base for Public Health Decision-Making?

17th Annual ISPOR

Lahue BJ, Lin AY, Crilly HJ

PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

ISPOR 2025, Value in Health 28(S1)

Lake D. Murphy; Betsy J. Lahue

How to Navigate the Digital Health Landscape: Global Value Frameworks and Payment Pathways

ISPOR 2024

Lahue BJ, Chandran A, Hernandez J

Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada

ISPOR 2024

Blackmore LTA, Cribbs KA, Lahue BJ

Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?

American Journal of Managed Care

Lahue BJ, Hughes K, Hills BJ, Li SS, Hiatt JC

Health technology assessment on cervical cancer screening, 2000-2014

Int J Technol Assess Health Care

Lahue BJ, Baginska E, Li SS, Parisia M

A Review of Health Technology Assessments (HTA) for Cervical Cancer Screening Technologies

17th Annual ISPOR

Lahue BH, Baginska E

Burden of Systemic Mastocytosis in Europe and the UK: Interim Results from PRISM Patient Survey

ECRD 2024

Hobart J, Radia DH, Triggiani M, Butt NM, Drummond M, Baisley W, Lahue BJ, Green T, Powell D, Gressier-Sayag C, Mesa R

The Burden of Systemic Mastocytosis in the EU: Evidence From the PRISM Patient Survey

ISPOR EU 2023

Mesa R, Triggiani M, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC

Assessment of Physician Treatment Preferences for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

National Comprehensive Cancer Network, Journal of the National Comprehensive Cancer Network

Gao W, Gaburo K, Lahue B, Davies K, Ukropec J, Jun M

Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: results of the TouchStone SM Patient Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC

Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

BMC Immunology

Mallick R, Henderson T, Lahue BJ, Kafal A, Bassett P, Scalchunes C

The Impact of Educational Home Visits on Children at Risk for Lead Poisoning

Centers For Disease Control Annual Grantees Meeting

[Lahue] Justason BJ

Enhancing graduate practicum project development and selection at schools of public health: A case study

Pedagogy in Health Promotion

Cribbs K, Lynch S, LaMonica M, Amadi C, Joshi A

Home care workers’ experiences of client death and disenfranchised grief

Qualitative Health Research

Tsui EK, Franzosa E, Cribbs KA, Baron S

Using advanced simulation modeling to examine the impact of increased resources on patient throughput in outpatient care

Value in Health

Lahue BJ, Lacey MJ, Dronzek R

Severity, Manifestations, and Consequences of Violence among Pregnant Adolescents

Journal of Adolescent Health

Covington DL, [Lahue] Justason BJ, Wright LN

Use of Continuous Quality Improvement Principles to Increase Preventive Screenings in High-Risk Infants

128th American Public Health Association Annual Meeting and Exposition

[Lahue] Justason BJ, Sachariat ML, McArtor RD